| CAR | Chimeric antigen receptor |
| CEA | Carcinoembryonic antigen |
| CIMP | CpG island methylator phenotype |
| CIN | Chromosomal instability |
| CRC | Colorectal cancer |
| CTLA-4 | Cytotoxic T-lymphocyte-associated antigen 4 |
| DC | Dendritic cell |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial-mesenchymal transition |
| EpCAM | Epithelial cell adhesion molecule |
| HER2 | Human epidermal growth factor receptor 2 |
| HLA | Human leukocyte antigen |
| IHP | Isolated hepatic perfusion |
| MDSC | Myeloid-derived suppressor cell |
| MHC | Major histocompatibility complex |
| MMR | Mismatch repair |
| MSI | Microsatellite instability |
| MSS | Microsatellite stable |
| MUC1 | Mucin 1 |
| NK | Natural killer |
| NKT | Natural killer T |
| PD-1 | Programmed death 1 |
| PD-L1 | Programmed death-ligand 1 |
| PD-L2 | Programmed death-ligand 2 |
| sHLA | Soluble HLA |
| TAM | Tumor-associated macrophage |
| TIL | Tumor-infiltrating lymphocyte |
| TP53 | Tumor protein 53 |
| Treg | Regulatory T cell |